BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24685781)

  • 1. The effects of phase III cardiac rehabilitation in serum and salivary Hs-CRP and anthropometric measurements in patients with coronary artery disease.
    Jamshidpour B; Moghadam BA; Vasaghi-Gharamaleki B; Mirzaii-Dizgah I; Nejatian M
    J Contemp Dent Pract; 2013 Sep; 14(5):819-24. PubMed ID: 24685781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 12 weeks of aerobic training on serum levels high sensitivity C-reactive protein, tumor necrosis factor-alpha, lipid profile and anthropometric characteristics in middle-age women patients with type 2 diabetes.
    Saghebjoo M; Nezamdoost Z; Ahmadabadi F; Saffari I; Hamidi A
    Diabetes Metab Syndr; 2018; 12(2):163-168. PubMed ID: 29287840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval training based on ventilatory anaerobic threshold increases cardiac vagal modulation and decreases high-sensitivity c-reative protein: randomized clinical trial in coronary artery disease.
    Tamburus NY; Paula RF; Kunz VC; César MC; Moreno MA; da Silva E
    Braz J Phys Ther; 2015; 19(6):441-50. PubMed ID: 26647745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population.
    Lin CC; Kardia SL; Li CI; Liu CS; Lai MM; Lin WY; Chang PC; Lee YD; Chen CC; Lin CH; Yang CW; Hsiao CY; Chen W; Li TC
    BMC Public Health; 2010 Sep; 10():579. PubMed ID: 20875142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of traditional obesity parameters in predicting the number of stenosed coronary arteries (≥ 60%) among patients undergoing cardiac catheterization.
    Hayajneh AA; Alhusban IM; Rababa M
    Sci Rep; 2022 Aug; 12(1):13830. PubMed ID: 35970873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of exercise training session duration in the rehabilitation of coronary artery disease patients.
    Hansen D; Dendale P; Berger J; Onkelinx S; Reyckers I; Hermans A; Vaes J; Reenaers V; Meeusen R
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):453-9. PubMed ID: 18677171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of anthropometric variables in C reactive protein].
    Timóteo AT; Miranda F; Feliciano J; Ferreira R
    Acta Med Port; 2011; 24(3):419-26. PubMed ID: 22015029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
    Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
    Mohan V; Deepa R; Velmurugan K; Premalatha G
    Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography.
    Seo WW; Kim HL; Kim YJ; Yoon YE; Lee SP; Kim HK; Cho GY; Zo JH; Choi DJ; Sohn DW
    J Cardiol; 2016 Sep; 68(3):222-8. PubMed ID: 26481470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
    Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
    Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease.
    Ntyintyane L; Panz V; Raal FJ; Gill G
    Metab Syndr Relat Disord; 2009 Jun; 7(3):243-8. PubMed ID: 19462476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.